Xylem (NYSE:XYL) has been assigned a $78.00 target price by investment analysts at Canaccord Genuity in a research note issued on Tuesday. The brokerage presently has a “hold” rating on the industrial products company’s stock. Canaccord Genuity’s target price would suggest a potential upside of 3.32% from the company’s current price.
Several other equities research analysts have also recently weighed in on the company. Zacks Investment Research raised Xylem from a “hold” rating to a “buy” rating and set a $84.00 price target for the company in a research note on Saturday, April 7th. BMO Capital Markets reiterated a “buy” rating and issued a $86.00 price target on shares of Xylem in a report on Friday, February 2nd. Seaport Global Securities reiterated a “buy” rating and issued a $83.00 price target on shares of Xylem in a report on Friday, February 2nd. Cowen reiterated a “buy” rating and issued a $80.00 price target on shares of Xylem in a report on Tuesday, March 6th. Finally, Oppenheimer increased their price target on Xylem to $82.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Five investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Xylem has an average rating of “Buy” and an average target price of $74.27.
Shares of XYL stock opened at $75.49 on Tuesday. The company has a quick ratio of 1.41, a current ratio of 1.88 and a debt-to-equity ratio of 0.87. Xylem has a twelve month low of $49.71 and a twelve month high of $79.83. The firm has a market cap of $14,123.40, a P/E ratio of 31.45, a price-to-earnings-growth ratio of 1.51 and a beta of 1.10.
Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, February 1st. The industrial products company reported $0.76 earnings per share for the quarter, hitting the consensus estimate of $0.76. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the company earned $0.66 EPS. Xylem’s revenue for the quarter was up 16.6% on a year-over-year basis. research analysts expect that Xylem will post 2.92 earnings per share for the current fiscal year.
In other news, insider Tomas Brannemo sold 1,151 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $76.41, for a total value of $87,947.91. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Curtis J. Crawford sold 7,948 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $71.77, for a total value of $570,427.96. Following the completion of the transaction, the director now owns 55,245 shares in the company, valued at approximately $3,964,933.65. The disclosure for this sale can be found here. Insiders sold 21,105 shares of company stock worth $1,540,907 in the last 90 days. Corporate insiders own 0.81% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of the stock. Xact Kapitalforvaltning AB increased its position in shares of Xylem by 17.9% during the fourth quarter. Xact Kapitalforvaltning AB now owns 38,383 shares of the industrial products company’s stock valued at $2,618,000 after acquiring an additional 5,830 shares during the last quarter. Handelsbanken Fonder AB increased its position in shares of Xylem by 1.4% during the fourth quarter. Handelsbanken Fonder AB now owns 706,000 shares of the industrial products company’s stock valued at $48,149,000 after acquiring an additional 10,000 shares during the last quarter. OLD Mutual Customised Solutions Proprietary Ltd. increased its position in shares of Xylem by 38.3% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 12,267 shares of the industrial products company’s stock valued at $837,000 after acquiring an additional 3,400 shares during the last quarter. Halsey Associates Inc. CT purchased a new stake in shares of Xylem during the fourth quarter valued at approximately $697,000. Finally, Meitav Dash Investments Ltd. purchased a new stake in shares of Xylem during the fourth quarter valued at approximately $1,194,000. 85.91% of the stock is owned by institutional investors.
WARNING: This piece of content was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/04/25/xylem-xyl-pt-set-at-78-00-by-canaccord-genuity.html.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.